View in EDS

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience.

Saved in:
Bibliographic Details
Title: Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience.
Authors: Shotton R; The Christie NHS Foundation Trust, Manchester, United Kingdom., Broadbent R; The Christie NHS Foundation Trust, Manchester, United Kingdom., Alchawaf A; The Christie NHS Foundation Trust, Manchester, United Kingdom., Mohamed MB; The Christie NHS Foundation Trust, Manchester, United Kingdom., Gibb A; The Christie NHS Foundation Trust, Manchester, United Kingdom., Martinez-Calle N; Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Fox CP; Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.; School of Medicine, University of Nottingham, Nottingham, United Kingdom., Bishton M; Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Pender A; Department of Medicine, The Royal Marsden Hospital, London, United Kingdom., Gleeson M; Haematology, The Royal Marsden Hospital, London, United Kingdom., Cunningham D; Haematology, The Royal Marsden Hospital, London, United Kingdom., Davies A; Cancer Research UK/NIHE Experimental Cancer Medicines Centre, University of Southampton, Southampton, United Kingdom., Yadollahi S; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Eyre TA; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Collins G; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Djebbari F; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Kassam S; Haematology, King's College Hospital, London, United Kingdom., Garland P; Haematology, King's College Hospital, Princess Royal Site, Kent, United Kingdom., Watts E; Haematology, Freeman Hospital, Newcastle, United Kingdom., Osborne W; Haematology, Freeman Hospital, Newcastle, United Kingdom., Townsend W; Haematology, University College Hospital London, London, United Kingdom., Pocock R; Haematology, University College Hospital London, London, United Kingdom., Ahearne MJ; Haematology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom., Miall F; Haematology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom., Wang X; Statistics Group, Clinical Outcome Unit, Digital Services, The Christie NHS Foundation Trust, Manchester, United Kingdom., Linton KM; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.
Source: Blood advances [Blood Adv] 2024 Feb 27; Vol. 8 (4), pp. 878-888.
Publication Type: Multicenter Study; Observational Study; Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37967358
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shotton+R%22">Shotton R</searchLink>; The Christie NHS Foundation Trust, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Broadbent+R%22">Broadbent R</searchLink>; The Christie NHS Foundation Trust, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Alchawaf+A%22">Alchawaf A</searchLink>; The Christie NHS Foundation Trust, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mohamed+MB%22">Mohamed MB</searchLink>; The Christie NHS Foundation Trust, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gibb+A%22">Gibb A</searchLink>; The Christie NHS Foundation Trust, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Martinez-Calle+N%22">Martinez-Calle N</searchLink>; Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fox+CP%22">Fox CP</searchLink>; Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.; School of Medicine, University of Nottingham, Nottingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bishton+M%22">Bishton M</searchLink>; Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pender+A%22">Pender A</searchLink>; Department of Medicine, The Royal Marsden Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gleeson+M%22">Gleeson M</searchLink>; Haematology, The Royal Marsden Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cunningham+D%22">Cunningham D</searchLink>; Haematology, The Royal Marsden Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Davies+A%22">Davies A</searchLink>; Cancer Research UK/NIHE Experimental Cancer Medicines Centre, University of Southampton, Southampton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Yadollahi+S%22">Yadollahi S</searchLink>; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Eyre+TA%22">Eyre TA</searchLink>; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Collins+G%22">Collins G</searchLink>; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Djebbari+F%22">Djebbari F</searchLink>; Haematology, Haematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kassam+S%22">Kassam S</searchLink>; Haematology, King's College Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Garland+P%22">Garland P</searchLink>; Haematology, King's College Hospital, Princess Royal Site, Kent, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Watts+E%22">Watts E</searchLink>; Haematology, Freeman Hospital, Newcastle, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Osborne+W%22">Osborne W</searchLink>; Haematology, Freeman Hospital, Newcastle, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Townsend+W%22">Townsend W</searchLink>; Haematology, University College Hospital London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pocock+R%22">Pocock R</searchLink>; Haematology, University College Hospital London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ahearne+MJ%22">Ahearne MJ</searchLink>; Haematology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Miall+F%22">Miall F</searchLink>; Haematology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Statistics Group, Clinical Outcome Unit, Digital Services, The Christie NHS Foundation Trust, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Linton+KM%22">Linton KM</searchLink>; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2024 Feb 27; Vol. 8 (4), pp. 878-888.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Multicenter Study; Observational Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37967358
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2023011305
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 878
    Titles:
      – TitleFull: Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shotton R
      – PersonEntity:
          Name:
            NameFull: Broadbent R
      – PersonEntity:
          Name:
            NameFull: Alchawaf A
      – PersonEntity:
          Name:
            NameFull: Mohamed MB
      – PersonEntity:
          Name:
            NameFull: Gibb A
      – PersonEntity:
          Name:
            NameFull: Martinez-Calle N
      – PersonEntity:
          Name:
            NameFull: Fox CP
      – PersonEntity:
          Name:
            NameFull: Bishton M
      – PersonEntity:
          Name:
            NameFull: Pender A
      – PersonEntity:
          Name:
            NameFull: Gleeson M
      – PersonEntity:
          Name:
            NameFull: Cunningham D
      – PersonEntity:
          Name:
            NameFull: Davies A
      – PersonEntity:
          Name:
            NameFull: Yadollahi S
      – PersonEntity:
          Name:
            NameFull: Eyre TA
      – PersonEntity:
          Name:
            NameFull: Collins G
      – PersonEntity:
          Name:
            NameFull: Djebbari F
      – PersonEntity:
          Name:
            NameFull: Kassam S
      – PersonEntity:
          Name:
            NameFull: Garland P
      – PersonEntity:
          Name:
            NameFull: Watts E
      – PersonEntity:
          Name:
            NameFull: Osborne W
      – PersonEntity:
          Name:
            NameFull: Townsend W
      – PersonEntity:
          Name:
            NameFull: Pocock R
      – PersonEntity:
          Name:
            NameFull: Ahearne MJ
      – PersonEntity:
          Name:
            NameFull: Miall F
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Linton KM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 02
              Text: 2024 Feb 27
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1